Dr Rutger Roring
Dr Rutger Roring
Details
Role
Research Officer
Research area
Infection, Immunity and Global Health
Group
Inflammatory Origins
Dr Rutger Röring is an early career postdoctoral researcher in the Inflammatory Origins group at the Murdoch Children's Research Institute.
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and PhD in Medical Sciences (thesis: "Regulatory Mechanisms of Trained Immunity in Vaccination and Disease") at Radboud University (Nijmegen, The Netherlands). His research experience encompasses a spectrum of experimental models in human immunology. His vision is that mechanistic in vitro experiments are key to understand and supplement 'real-world' human evidence from cohort studies and clinical trials.
At MCRI, Dr Röring works in the Inflammatory Origins Group, a team of specialists in diverse areas that seeks to understand the key roles that inflammation and infection play in the development of cardiovascular and metabolic disease (heart disease, stroke, type 2 diabetes and obesity), the leading causes of illness and death in Australia and worldwide. Dr Röring's laboratory expertise is vital to extracting the maximal amount of information from the precious childhood biosamples available in the Inflammatory Origins biobanks and clinical cohorts.
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and PhD in Medical Sciences (thesis: "Regulatory Mechanisms of Trained Immunity in Vaccination and Disease") at Radboud University (Nijmegen, The Netherlands). His research experience encompasses a spectrum of experimental models in human immunology. His vision is that mechanistic in vitro experiments are key to understand and supplement 'real-world' human evidence from cohort studies and clinical trials.
At MCRI, Dr Röring works in the Inflammatory Origins Group, a team of specialists in diverse areas that seeks to understand the key roles that inflammation and infection play in the development of cardiovascular and metabolic disease (heart disease, stroke, type 2 diabetes and obesity), the leading causes of illness and death in Australia and worldwide. Dr Röring's laboratory expertise is vital to extracting the maximal amount of information from the precious childhood biosamples available in the Inflammatory Origins biobanks and clinical cohorts.
Dr Rutger Röring is an early career postdoctoral researcher in the Inflammatory Origins group at the Murdoch Children's Research Institute.
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and...
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and...
Dr Rutger Röring is an early career postdoctoral researcher in the Inflammatory Origins group at the Murdoch Children's Research Institute.
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and PhD in Medical Sciences (thesis: "Regulatory Mechanisms of Trained Immunity in Vaccination and Disease") at Radboud University (Nijmegen, The Netherlands). His research experience encompasses a spectrum of experimental models in human immunology. His vision is that mechanistic in vitro experiments are key to understand and supplement 'real-world' human evidence from cohort studies and clinical trials.
At MCRI, Dr Röring works in the Inflammatory Origins Group, a team of specialists in diverse areas that seeks to understand the key roles that inflammation and infection play in the development of cardiovascular and metabolic disease (heart disease, stroke, type 2 diabetes and obesity), the leading causes of illness and death in Australia and worldwide. Dr Röring's laboratory expertise is vital to extracting the maximal amount of information from the precious childhood biosamples available in the Inflammatory Origins biobanks and clinical cohorts.
Before starting his work at MCRI, Rutger completed a Master's degree in Molecular Mechanisms of Disease and PhD in Medical Sciences (thesis: "Regulatory Mechanisms of Trained Immunity in Vaccination and Disease") at Radboud University (Nijmegen, The Netherlands). His research experience encompasses a spectrum of experimental models in human immunology. His vision is that mechanistic in vitro experiments are key to understand and supplement 'real-world' human evidence from cohort studies and clinical trials.
At MCRI, Dr Röring works in the Inflammatory Origins Group, a team of specialists in diverse areas that seeks to understand the key roles that inflammation and infection play in the development of cardiovascular and metabolic disease (heart disease, stroke, type 2 diabetes and obesity), the leading causes of illness and death in Australia and worldwide. Dr Röring's laboratory expertise is vital to extracting the maximal amount of information from the precious childhood biosamples available in the Inflammatory Origins biobanks and clinical cohorts.
Top Publications
- Becker, AMD, Decker, AH, Flórez-Grau, G, Bakdash, G, Röring, RJ, Stelloo, S, Vermeulen, M, Piet, B, Aarntzen, EHJG, Verdoes, M, et al. Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.. Cell Rep Med 5(2) : 101386 2024 view publication
- Röring, RJ, Debisarun, PA, Botey-Bataller, J, Suen, TK, Bulut, Ö, Kilic, G, Koeken, VA, Sarlea, A, Bahrar, H, Dijkstra, H, et al. MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells.. J Clin Invest 134(7) : 2024 view publication
- Schrijver, DP, Röring, RJ, Deckers, J, de Dreu, A, Toner, YC, Prevot, G, Priem, B, Munitz, J, Nugraha, EG, van Elsas, Y, et al. Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells.. Nat Biomed Eng 7(9) : 1097 -1112 2023 view publication
- Domínguez-Andrés, J, Arts, RJW, Bekkering, S, Bahrar, H, Blok, BA, de Bree, LCJ, Bruno, M, Bulut, Ö, Debisarun, PA, Dijkstra, H, et al. In vitro induction of trained immunity in adherent human monocytes.. STAR Protoc 2(1) : 100365 2021 view publication
- Röring, RJ, Scognamiglio, F, de Jong, LC, Groh, LA, Matzaraki, V, Koeken, VACM, Joosten, LAB, Ziogas, A, Netea, MG. Interleukin-10 inhibits important components of trained immunity in human monocytes.. J Leukoc Biol 117(3) : 2025 view publication
Page 1 of 4
